Skip to main navigation Skip to search Skip to main content

Psychopathological characteristics in patients with arginine vasopressin deficiency (central diabetes insipidus) and primary polydipsia compared to healthy controls

  • Cihan Atila
  • , Julia Beck
  • , Julie Refardt
  • , Zoran Erlic
  • , Juliana B. Drummond
  • , Clara O. Sailer
  • , Matthias E. Liechti
  • , Beatriz Santana Soares Rocha
  • , Felix Beuschlein
  • , Bettina Winzeler
  • , Mirjam Christ-Crain*
  • *Corresponding author for this work
  • Universitätsspital Basel
  • University of Basel
  • University Hospital Basel
  • University Hospital Zürich
  • Universidade Federal de Minas Gerais
  • Klinikum der Universität München
  • LOOBesity

Research output: Contribution to journalArticleAcademicpeer-review

7 Citations (Scopus)
60 Downloads (Pure)

Abstract

Objective: 

Distinguishing arginine vasopressin deficiency (AVP-D; central diabetes insipidus) from primary polydipsia (PP), commonly referred to as psychogenic polydipsia, is challenging. Psychopathologic findings, commonly used for PP diagnosis in clinical practice, are rarely evaluated in AVP-D patients, and no comparative data between the two conditions currently exist. 

Design: 

Data from two studies involving 82 participants [39 AVP-D, 28 PP, and 15 healthy controls (HC)]. 

Methods: 

Psychological evaluations were conducted using standardized questionnaires measuring anxiety [State-Trait Anxiety Inventory (STAI)], alexithymia [Toronto Alexithymia Scale (TAS-20)], depressive symptoms (Beck’s Depression Inventory-II (BDI-II), and overall mental health [Short Form-36 Health Survey (SF-36)]. Higher STAI, TAS-20, and BDI-II scores suggest elevated anxiety, alexithymia, and depression, while higher SF-36 scores signify better overall mental health. 

Results: 

Compared to HC, patients with AVP-D and PP showed higher levels of anxiety (HC 28 points [24–31] vs AVP-D 36 points [31–45]; vs PP 38 points [33–46], P < .01), alexithymia (HC 30 points [29–37] vs AVP-D 43 points [35–54]; vs PP 46 points [37–55], P < .01), and depression (HC 1 point [0–2] vs AVP-D 7 points [4–14]; vs PP 7 points [3–13], P < .01). Levels of anxiety, alexithymia, and depression showed no difference between both patient groups (P = .58, P = .90, P = .50, respectively). Compared to HC, patients with AVP-D and PP reported similarly reduced self-reported overall mental health scores (HC 84 [68–88] vs AVP-D 60 [52–80], P = .05; vs PP 60 [47–74], P < .01).

Conclusion: 

This study reveals heightened anxiety, alexithymia, depression, and diminished overall mental health in patients with AVP-D and PP. The results emphasize the need for careful interpretation of psychopathological characteristics to differentiate between AVP-D and PP.

Original languageEnglish
Pages (from-to)354-362
Number of pages9
JournalEuropean Journal of Endocrinology
Volume190
Issue number5
DOIs
Publication statusPublished - May 2024

Bibliographical note

Publisher Copyright:
© 2024 Oxford University Press. All rights reserved.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Psychopathological characteristics in patients with arginine vasopressin deficiency (central diabetes insipidus) and primary polydipsia compared to healthy controls'. Together they form a unique fingerprint.

Cite this